Derma Sciences Hit With Suits Over $204M Integra Buy
Integra LifeSciences Holdings Corp.'s proposal to buy Derma Sciences Inc. is unfair to shareholders because it undervalues the company and unfairly rewards Derma Sciences executives, according to proposed class actions filed...To view the full article, register now.
Already a subscriber? Click here to view full article